Skip to main content
. 2021 Apr 12;12:640032. doi: 10.3389/fphar.2021.640032
-GRADE No prospective randomized clinical trials were found investigating genotyping before starting treatment with a psychopharmacon and comparing genotype adjusted dosing to standard care with regard to clinical outcome (clinical effect and/or side effects). These studies were not found for patients using antidepressants and neither for antipsychotics.